Clinical Trials
2 trialsNCT03049462 2026-05-22
The Physiological Responses and Adaptation of Brown Adipose Tissue to Chronic Treatment With Beta3-Adrenergic Receptor Agonists
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT07261683 2025-12-19
Phase II Study of Weekly Paclitaxel/Nab-Paclitaxel, Pembrolizumab, and Mirabegron for Recurrent Ovarian Cancer
Obstetrics & Gynecology Hospital of Fudan University
Phase 2 Recruiting